Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Sales: 2011-2016

Historic Return on Sales for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to -29.97%.

  • Tenax Therapeutics' Return on Sales was N/A to -29.97% in Q4 2016 from the same period last year, while for Dec 2016 it was -29.97%, marking a year-over-year change of. This contributed to the annual value of 765.35% for FY2024, which is 44143.00% up from last year.
  • As of Q4 2016, Tenax Therapeutics' Return on Sales stood at -29.97%, which was up 36.16% from -46.94% recorded in Q2 2013.
  • In the past 5 years, Tenax Therapeutics' Return on Sales registered a high of -9.22% during Q1 2013, and its lowest value of -46.94% during Q2 2013.
  • In the last 1 years, Tenax Therapeutics' Return on Sales had a median value of -29.97% in 2016 and averaged -29.97%.
  • In the last 5 years, Tenax Therapeutics' Return on Sales tumbled by 18,623bps in 2012 and then skyrocketed by 2,326bps in 2013.
  • Tenax Therapeutics' Return on Sales (Quarterly) stood at -14.55% in 2012, then slumped by 397bps to -46.94% in 2013, then reached -29.97% in 2016.
  • Its Return on Sales stands at -29.97% for Q4 2016, versus -46.94% for Q2 2013 and -9.22% for Q1 2013.